In the news!
Press Releases
Myonexus Therapeutics, Inc. Launches to Develop Pioneering, Clinical-Stage Gene Therapies Targeting Limb-Girdle Muscular Dystrophies 150 150 Myonexus Therapeutics

Myonexus Therapeutics, Inc. Launches to Develop Pioneering, Clinical-Stage Gene Therapies Targeting Limb-Girdle Muscular Dystrophies

Innovative Gene Therapies with Potential to Become First-ever, Standard of Care Therapies for Limb-Girdle Muscular Dystrophies Announces Management Team of Industry Leaders with Technical and Commercial Expertise in Muscular Dystrophy Gene Therapy, Pharmaceuticals, and New Venture Development Licenses Innovative Gene Therapy Technologies from Nationwide Children’s Hospital, Columbus, Ohio Secures Initial Financing from Global Limb-Girdle Muscular…

read more